Laparoscopic Ultra-radical Lymph Node Debulking Using Yasargil Clamps for Gynecological Malignancies: Results from a Large, Multicenter, Retrospective Analysis.


Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
09 2022
Historique:
received: 12 04 2022
revised: 24 05 2022
accepted: 25 05 2022
pubmed: 2 6 2022
medline: 14 9 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Resection of bulky lymph nodes in gynecologic oncology is a challenging procedure. Considering the risk of intraoperative vascular injury, a technique to avoid severe complications is mandatory. In this study, we aimed to analyze the feasibility of laparoscopic ultraradical lymph node debulking using Yasargil clamps in patients with gynecologic cancer with bulky lymph node metastases. Multicenter retrospective case series (ClinicalTrialg.gov ID: NCT05318170), between September 2010 and April 2020. Units of Gynecologic Oncology. Patients with gynecologic cancer with bulky lymph node metastases. Laparoscopic ultraradical lymph node debulking using Yasargil clamps. Forty-three patients with gynecologic cancer with bulky pelvic and/or aortic lymph nodes metastases undergoing laparoscopic lymph node debulking surgery using Yasargil clamps were included. Median surgical time was 300 minutes (range, 120-550 minutes); median estimated blood loss was 170 mL (range, 0-700 mL). Median size of lymph nodes was 50 mm (range, 25-100). R0 resection was achieved in all cases. Four intraoperative complications (9.3%) occurred. No conversion to open surgery was required. There were 8 postoperative complications, classified grade 2 or worse. There were no cases with intra- or postoperative mortality. In our experience, in carefully selected patients with gynecologic cancer with bulky lymph nodes, laparoscopic lymph node debulking using Yasargil clamps could be considered a valid option to avoid potential severe vascular intraoperative complications.

Identifiants

pubmed: 35649479
pii: S1553-4650(22)00213-8
doi: 10.1016/j.jmig.2022.05.016
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT05318170']

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1083-1091

Informations de copyright

Copyright © 2022 AAGL. Published by Elsevier Inc. All rights reserved.

Auteurs

Mariano Catello Di Donna (MC)

Unit of Gynecologic Oncology, ARNAS "Civico - Di Cristina - Benfratelli", Palermo, Italy (Drs. Di Donna, Sozzi, Cucinella, Giallombardo, Laganà, and Chiantera); Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Palermo, Italy (Dr. Di Donna).

Giulio Sozzi (G)

Unit of Gynecologic Oncology, ARNAS "Civico - Di Cristina - Benfratelli", Palermo, Italy (Drs. Di Donna, Sozzi, Cucinella, Giallombardo, Laganà, and Chiantera).

Giuseppe Cucinella (G)

Unit of Gynecologic Oncology, ARNAS "Civico - Di Cristina - Benfratelli", Palermo, Italy (Drs. Di Donna, Sozzi, Cucinella, Giallombardo, Laganà, and Chiantera).

Vincenzo Giallombardo (V)

Unit of Gynecologic Oncology, ARNAS "Civico - Di Cristina - Benfratelli", Palermo, Italy (Drs. Di Donna, Sozzi, Cucinella, Giallombardo, Laganà, and Chiantera).

Valerio Gallotta (V)

Department of Woman's and Child Health and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy (Drs. Gallotta and Scambia).

Stefano Uccella (S)

Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy (Drs. Uccella and.

Simone Garzon (S)

Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy (Drs. Uccella and.

Giovanni Scambia (G)

Department of Woman's and Child Health and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy (Drs. Gallotta and Scambia).

Antonio Simone Laganà (AS)

Unit of Gynecologic Oncology, ARNAS "Civico - Di Cristina - Benfratelli", Palermo, Italy (Drs. Di Donna, Sozzi, Cucinella, Giallombardo, Laganà, and Chiantera); Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy (Drs. Laganà and Chiantera). Electronic address: antoniosimone.lagana@unipa.it.

Vito Chiantera (V)

Unit of Gynecologic Oncology, ARNAS "Civico - Di Cristina - Benfratelli", Palermo, Italy (Drs. Di Donna, Sozzi, Cucinella, Giallombardo, Laganà, and Chiantera); Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy (Drs. Laganà and Chiantera).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH